10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
On Friday, the Federal Trade Commission (“FTC”) and the Antitrust Division of the U.S. Department ...
Read More >
While the vast majority of Proposition 65 claims involve consumer products, Proposition 65 also appl...
Read More >
China has moved to strengthen its review of foreign direct investments in 2020 - The PRC Foreign I...
Read More >
Patient Recruiter Convicted in $1.3 Million Kickback Conspiracy Scheme - After a six-day trial, a ...
Read More >
In response to Hurricane Dorian, Governor Ron DeSantis has issued Executive Order No. 19-190 (reaffi...
Read More >
In order to support the District of Columbia’s new Universal Paid Leave Act (the Act), covered empl...
Read More >